1 / 9

Advancing IP Reference Standards: Challenges and Opportunities for Indian Pharma Industry

The development of Indian Pharmacopoeia (IP) Reference Standards (RS) is crucial for the pharmaceutical industry’s growth. With upgraded methods and new monographs, IP aims to lead in therapeutic areas, including herbal medicines. However, challenges remain, such as limited catalogues, scientific rigor in evaluation, and effective supply chain logistics. Establishing well-equipped laboratories and fostering industry participation are vital for developing a successful RS program. Increased public awareness and collaboration with international standards organizations can enhance the global acceptance of IP and elevate India's pharmaceutical sector.

mara-randolph
Télécharger la présentation

Advancing IP Reference Standards: Challenges and Opportunities for Indian Pharma Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IPA- EDQM SYMPOSIUM 2007REFERENCE STANDARD DEVELOPMENT -IP PERSPECTIVE A.R Gomes – Sr.Director, Quality Control Dr.Reddy’s Laboratories.

  2. IP Reference Standards - changing times!! • Pharma business in India poised for great leap • IP 2007 – upgraded methods/monographs • First time monographs – many therapeutic areas • May assume leadership in herbals • Monograph’s dependency on RS – in the increase • Cost is not a deterrence for science – changing mindsets • Acceptability of IP in the region - availability of RS is essential. • Global acceptance – a rightful national ambition

  3. IP RS – current challenges • Not as organized as others in the league • Thin catalogue – doesn’t have them all • Availability • Scientific rigor • Industry participation • Evaluation/ Characterization – public awareness • Logistics – supply chain • Lot continuance – evaluation

  4. IP RS – suggested way forward!! • Well organized structure for RS program • Setting up well equipped and manned RS evaluation laboratories • Approval/ Accreditation of labs for RS certification • Advanced analytical techniques – Industry support • Establishing robust work flow from procurement , distribution till lot continuation evaluation. • Public awareness through general chapter in IP • Seeking and securing widespread industry participation

  5. IP RS – feasible work flow • Arrive on a list of priority items (IP 2007 ref) • Procurement of candidate material from Industry • Processing/synthesis of impurities – national /industry labs • Establish systems for storage of candidate materials • Mechanism for preparing evaluation protocol • Identify collaborative labs (national/industry/regulatory) • Send samples and protocol for testing • For new materials – complete characterization and mass balance approach • For materials for which already well established RS available, then use them as primary for determining potency in addition to identity (?)

  6. IP RS – feasible work flow • Sponsors data – usage policy should be available • Usage of industry analytical support on advanced test requirements • Collection and review of analytical data • Approval of data and label instructions • Packing of RS in suitable packs • Labeling and identification • Distribution • Cold chain , normal , special pack – SOP’s • Lot continuity study

  7. IP RS – feasible work flow • Listing of available standards in catalogue/web • Creating accessibility – commercial and scientific • Liaison of RS and specific monographs to address issues • Training of scientific and supply chain staff • Utilizing IP committee for establishing scientific rigor • Customer complaint handling mechanism • Information to customers on status of lot • Partner with USP/EP for gaining expertise and mutual benefits of avoiding duplication and hence cut cost • Keeping neutral autonomy position

  8. IP RS – Conclusion • The relevance and significant is more than ever • Integral to industry in its current growth • High obligation to the industry in its future outlook • Opportunity to play global lead in selected therapies • Industry if tapped rightly can significantly contribute to the program and raise standards • The quality and acceptability of IP can be achieved only through an excellent RS program • Participation in global standard setting exercises • Time is now !

  9. Thank You

More Related